Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

作者: Arianna Calcinotto , Maurilio Ponzoni , Roberto Ria , Matteo Grioni , Elena Cattaneo

DOI: 10.1080/2162402X.2015.1008850

关键词:

摘要: While multiple myeloma (MM) is almost invariably preceded by asymptomatic monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering MM (SMM), the alterations bone marrow (BM) microenvironment that establish progression to symptomatic disease are circumstantial. Here we show in Vk*MYC mice harboring oncogene-driven plasma cell proliferative disorder, appearance associated with substantial modifications BM microenvironment, including a progressive accumulation both CD8+ and CD4+ T cells dominant helper type 1 (Th1) response. Progression from was characterized further accrual reduced Th1 persistently increased Th2 cytokine production, which CD206+Tie2+ macrophages, pro-angiogenic cytokines microvessel density (MVD). Notably, MVD also at diagnosis MGUS SMM patients subsequently progressed when compared remained quiescent. These findings suggest multistep pathogenic process MM, immune system may contribute angiogenesis progression. They initiating large multicenter study investigate as prognostic factor for outcome this disease.

参考文章(49)
Donna Weber, Kim Rankin, Maria Gavino, Kay Delasalle, Raymond Alexanian, Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma Journal of Clinical Oncology. ,vol. 21, pp. 16- 19 ,(2003) , 10.1200/JCO.2003.03.139
Angela Dispenzieri, Philip R. Greipp, Thomas E. Witzig, S. Vincent Rajkumar, John A. Lust, Morie A. Gertz, Robert A. Kyle, Rafael Fonseca, Patrick C. Roche, Traci Leong, Martha Q. Lacy, Prognostic Value of Bone Marrow Angiogenesis in Multiple Myeloma Clinical Cancer Research. ,vol. 6, pp. 3111- 3116 ,(2000)
Kenneth C. Anderson, Ruben D. Carrasco, Pathogenesis of Myeloma Annual Review of Pathology: Mechanisms of Disease. ,vol. 6, pp. 249- 274 ,(2011) , 10.1146/ANNUREV-PATHOL-011110-130249
María-Victoria Mateos, Miguel-Teodoro Hernández, Pilar Giraldo, Javier de la Rubia, Felipe de Arriba, Lucía López Corral, Laura Rosiñol, Bruno Paiva, Luis Palomera, Joan Bargay, Albert Oriol, Felipe Prosper, Javier López, Eduardo Olavarría, Nuria Quintana, José-Luis García, Joan Bladé, Juan-José Lahuerta, Jesús-F. San Miguel, Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma New England Journal of Medicine. ,vol. 369, pp. 438- 447 ,(2013) , 10.1056/NEJMOA1300439
Brunangelo Falini, Marco Fizzotti, Alessandra Pucciarini, Barbara Bigerna, Teresa Marafioti, Marcello Gambacorta, Roberta Pacini, Cristina Alunni, Laura Natali–Tanci, Barbara Ugolini, Carla Sebastiani, Giorgio Cattoretti, Stefano Pileri, Riccardo Dalla-Favera, Harald Stein, None, A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells Blood. ,vol. 95, pp. 2084- 2092 ,(2000) , 10.1182/BLOOD.V95.6.2084
Alpana Sharma, Rehan Khan, Suhasini Joshi, Lalit Kumar, Manoj Sharma, Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma. Leukemia & Lymphoma. ,vol. 51, pp. 920- 927 ,(2010) , 10.3109/10428191003699563
P. Leif Bergsagel, W. Michael Kuehl, Fenghuang Zhan, Jeffrey Sawyer, Bart Barlogie, John Shaughnessy, Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma Blood. ,vol. 106, pp. 296- 303 ,(2005) , 10.1182/BLOOD-2005-01-0034
Angelo Vacca, Domenico Ribatti, Marco Presta, Monica Minischetti, Monica Iurlaro, Roberto Ria, Adriana Albini, Federico Bussolino, Franco Dammacco, Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood. ,vol. 93, pp. 3064- 3073 ,(1999) , 10.1182/BLOOD.V93.9.3064
G Sortino, G Palumbo, F Di Raimondo, P Floridia, R Giustolisi, MP Azzaro, S Bagnato, G Giustolisi, Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood Haematologica. ,vol. 85, pp. 800- 805 ,(2000) , 10.3324/%X